SlideShare a Scribd company logo
BARIATRIC SURGERY IMPACT ON HEALTHCARE UTILIZATION IN A BRAZILIAN PRIVATE HEALTHCARE
PROVIDER
Silvana M B Kelles, Luíza O Rodrigues, Augusto C S Santos Júnior, Daniela C Azevedo, Lélia M A Carvalho, Maria da Glória C Horta, Mariana R
Fernandes, Sandra O S Avelar, Carla J Machado, Sandhi M Barreto.
UNIMED BH and Universidade Federal de Minas Gerais (UFMG)
ABSTRACT
METHODS
RESULTS - TABLE
In Brazil, the prevalence of obesity is steadily increasing at a rate of 0.89% per year. It is currently well
known that obese and extremely obese individuals are more likely to have associated comorbidities,
lower quality of life and shorter life expectancy compared to normal-weight individuals.
Also, morbidly obese individuals increase their health care utilization and cost in about 81% when
compared to a non-obese population, and in 47% when compared to a non-morbidly obese population.
Clinical benefits of bariatric surgery seem established, such as sustainable weight loss and reduction in
the prevalence of obesity-related comorbidities. On the other hand, its mid-term impact on healthcare
utilization and costs remains controversial. Thus, the objectives of this study was to analyze healthcare
use and expenditures, before and after bariatric surgery, in a cohort of Brazilian patients assisted by an
HMO (UNIMED BH).
RESULTS
This study consisted of a health insurance database analysis, from which before-and-after utilization
profile, per-operative problems, long-term surgical complications, and cost-utility issues were obtained
for all patients who underwent bariatric surgery (from January 2004 to December 2010). Patients
fulfilled the following bariatric surgery eligibility criteria, established by The National Institutes of
Health: BMI≥40 kg/m² or BMI ≥35 kg/m² and comorbid conditions, such as hypertension, diabetes,
sleep apnea, or severe arthropathy. Individuals under 18 years of age were excluded. Data concerning
healthcare costs and utilization were retrospectively analyzed, excluding the six months immediately
before or after surgery.
RESULTS
During the study period, 4,006 patients underwent bariatric surgery. Patients’ baseline characteristics
were: mean age of 36.2 (SD 10.3) years, mean BMI of 42.8 (SD 4.8) kg/m², and 80% were women. There
was a consistent increase in hospital admissions after surgery (total admissions were 740 vs. 1,231;
p<0.001), even when hospitalizations for plastic surgery or pregnancy-related were excluded, with a
global rate of 11.89 vs. 30.18 hospitalizations per 1,000 patients/year (p<0.001).
Visits to the emergency room (ER) were less frequent in the first year, but more frequent in the third
year of follow up. The overall rates of ER visits were 189.61 visits per 1,000 patients/year before surgery
and 170.18 after (p=0.022). The overall healthcare expenses before and after the surgery were US$ 350
and US$ 520 per person per year, respectively (p<0.001).
Figure 1: Rate of hospital admissions in the 4 years before and after bariatric surgery (excluding the six months
immediately before and after surgery and the admissions related to plastic surgery or pregnancy). The differences
between the respective years before and after surgery were all statistically significant (P<0.05).
Hospital admissions per 1,000 patients/year
BARIATRIC SURGERY IMPACT ON HEALTHCARE UTILIZATION IN A BRAZILIAN PRIVATE HEALTHCARE
PROVIDER
Silvana M B Kelles, Luíza O Rodrigues, Augusto C S Santos Júnior, Daniela C Azevedo, Lélia M A Carvalho, Maria da Glória C Horta, Mariana R
Fernandes, Sandra O S Avelar, Carla J Machado, Sandhi M Barreto.
UNIMED BH and Universidade Federal de Minas Gerais (UFMG)
RESULTSRESULTS CONCLUSIONS
Figure 2: Average health care expenditures per patient, per semester, during the four years before (B) and
after (A) bariatric surgery.
1. Fontaine KR, Redden DT, Wang C, Westfall AO, Allison DB. Years of life lost due to obesity. JAMA
2003;289:187-93.
2. Malta DC, Andrade SC, Claro RM, Bernal RTI, Monteiro CA. Trends in prevalence of overweight and
obesity in adults in 26 Brazilian state capitals and the Federal District from 2006 to 2012. Rev Bras
Epidemiol. 2014;17 Suppl 1:267-276..
3. Boido A, Ceriani V, Cetta F, Lombardi F, Pontiroli AE. Bariatric surgery and prevention of
cardiovascular events and mortality in morbid obesity: mechanisms of action and choice of surgery.
Nutr Metab Cardiovasc Dis. 2015.
4. KELLES SMB, MACHADO CJ, BARRETO SM. Ten-years of bariatric surgery in Brazil: in-hospital
mortality rates for patients assisted by universal health system or a health maintenance organization.
ABCD Arq Bras Cir Dig (São Paulo). 2014;27(4):261-267.
REFERENCES
Costs and hospital admissions increased consistently after bariatric surgery, even when elective or
pregnancy-related interventions were excluded. Healthcare providers and policy makers must be aware
that a decrease in obesity-related diseases following bariatric surgery does not necessarily result in
lower mid-term healthcare utilization or costs. Time trends illustrated in this study suggest that
healthcare costs might decrease to pre-surgery levels in the long term.
Healthcare providers must also consider a broader evaluation of healthcare utilization and costs
associated with bariatric surgery, including the impacts on quality of life, mortality and morbidity
associated with the surgery, and daily use of medication, in order to provide a more comprehensive
evaluation of changes before and after surgery.

More Related Content

What's hot

'Living Well' Conference 2013: The National Context of Survivorship
'Living Well' Conference 2013: The National Context of Survivorship'Living Well' Conference 2013: The National Context of Survivorship
'Living Well' Conference 2013: The National Context of Survivorship
PennyBrohnComms
 
Chapter 24.2 lmwh in cancer asso thrombosis
Chapter 24.2 lmwh in cancer asso thrombosisChapter 24.2 lmwh in cancer asso thrombosis
Chapter 24.2 lmwh in cancer asso thrombosis
Nilesh Kucha
 
Peter Najjar: Clinical Care and Quality Overview
Peter Najjar: Clinical Care and Quality OverviewPeter Najjar: Clinical Care and Quality Overview
Peter Najjar: Clinical Care and Quality Overview
NIHACS2015
 
34320294 jak inhibitors more than just glucocorticoids (1)
34320294  jak inhibitors   more than just glucocorticoids (1)34320294  jak inhibitors   more than just glucocorticoids (1)
34320294 jak inhibitors more than just glucocorticoids (1)
EVELIN LÁZARO
 
SUNRISE Study
SUNRISE StudySUNRISE Study
SUNRISE Study
Timothy Decker
 
Breast cancer ppt
Breast cancer pptBreast cancer ppt
Breast cancer ppt
Dr. PETETI SAIRAM
 
Denise Lee Publication
Denise Lee PublicationDenise Lee Publication
Denise Lee Publication
Denise Lee
 
Aboriginal Patterns of Cancer Care Project Breast Cancer paper BMCCancer 1471...
Aboriginal Patterns of Cancer Care Project Breast Cancer paper BMCCancer 1471...Aboriginal Patterns of Cancer Care Project Breast Cancer paper BMCCancer 1471...
Aboriginal Patterns of Cancer Care Project Breast Cancer paper BMCCancer 1471...
Cancer Council NSW
 
Current Issues Affecting Cancer Care in Puerto Rico
Current Issues Affecting Cancer Care in Puerto RicoCurrent Issues Affecting Cancer Care in Puerto Rico
Current Issues Affecting Cancer Care in Puerto Rico
flasco_org
 
Cancer de la región anal 2019
Cancer de la región anal 2019Cancer de la región anal 2019
Cancer de la región anal 2019
Efraín A. Medina Villaseñor,FACS
 
Measuring patient experience
Measuring patient experienceMeasuring patient experience
Measuring patient experience
Lorena Tonarelli M.Sc.
 
Cancer survival mortality_and_incidence_7_countries_1568689974
Cancer survival mortality_and_incidence_7_countries_1568689974Cancer survival mortality_and_incidence_7_countries_1568689974
Cancer survival mortality_and_incidence_7_countries_1568689974
RamiroCazco2
 
Cancer survival: what is the role of body composition pre- and post-diagnosis...
Cancer survival: what is the role of body composition pre- and post-diagnosis...Cancer survival: what is the role of body composition pre- and post-diagnosis...
Cancer survival: what is the role of body composition pre- and post-diagnosis...
World Cancer Research Fund International
 
Jco 2010-rizzo-jco.2010.29.2201
Jco 2010-rizzo-jco.2010.29.2201Jco 2010-rizzo-jco.2010.29.2201
Jco 2010-rizzo-jco.2010.29.2201
Clinica de imagenes
 
Pituitary Tumor Endocrinopathies
Pituitary Tumor EndocrinopathiesPituitary Tumor Endocrinopathies
Pituitary Tumor Endocrinopathies
Ade Wijaya
 
Aspirin Associated With Reduced Mortality in Patients With CRC.2015
Aspirin Associated With Reduced Mortality in Patients With CRC.2015Aspirin Associated With Reduced Mortality in Patients With CRC.2015
Aspirin Associated With Reduced Mortality in Patients With CRC.2015
hivlifeinfo
 
The prevalence and characteristics of fibromyalgia in the 2012 national healt...
The prevalence and characteristics of fibromyalgia in the 2012 national healt...The prevalence and characteristics of fibromyalgia in the 2012 national healt...
The prevalence and characteristics of fibromyalgia in the 2012 national healt...
Paul Coelho, MD
 
Tratamiento con osteobios en mujeres menopáusicas
Tratamiento con osteobios en mujeres menopáusicasTratamiento con osteobios en mujeres menopáusicas
Tratamiento con osteobios en mujeres menopáusicas
Naturpharma (Medicina Biológica)
 

What's hot (18)

'Living Well' Conference 2013: The National Context of Survivorship
'Living Well' Conference 2013: The National Context of Survivorship'Living Well' Conference 2013: The National Context of Survivorship
'Living Well' Conference 2013: The National Context of Survivorship
 
Chapter 24.2 lmwh in cancer asso thrombosis
Chapter 24.2 lmwh in cancer asso thrombosisChapter 24.2 lmwh in cancer asso thrombosis
Chapter 24.2 lmwh in cancer asso thrombosis
 
Peter Najjar: Clinical Care and Quality Overview
Peter Najjar: Clinical Care and Quality OverviewPeter Najjar: Clinical Care and Quality Overview
Peter Najjar: Clinical Care and Quality Overview
 
34320294 jak inhibitors more than just glucocorticoids (1)
34320294  jak inhibitors   more than just glucocorticoids (1)34320294  jak inhibitors   more than just glucocorticoids (1)
34320294 jak inhibitors more than just glucocorticoids (1)
 
SUNRISE Study
SUNRISE StudySUNRISE Study
SUNRISE Study
 
Breast cancer ppt
Breast cancer pptBreast cancer ppt
Breast cancer ppt
 
Denise Lee Publication
Denise Lee PublicationDenise Lee Publication
Denise Lee Publication
 
Aboriginal Patterns of Cancer Care Project Breast Cancer paper BMCCancer 1471...
Aboriginal Patterns of Cancer Care Project Breast Cancer paper BMCCancer 1471...Aboriginal Patterns of Cancer Care Project Breast Cancer paper BMCCancer 1471...
Aboriginal Patterns of Cancer Care Project Breast Cancer paper BMCCancer 1471...
 
Current Issues Affecting Cancer Care in Puerto Rico
Current Issues Affecting Cancer Care in Puerto RicoCurrent Issues Affecting Cancer Care in Puerto Rico
Current Issues Affecting Cancer Care in Puerto Rico
 
Cancer de la región anal 2019
Cancer de la región anal 2019Cancer de la región anal 2019
Cancer de la región anal 2019
 
Measuring patient experience
Measuring patient experienceMeasuring patient experience
Measuring patient experience
 
Cancer survival mortality_and_incidence_7_countries_1568689974
Cancer survival mortality_and_incidence_7_countries_1568689974Cancer survival mortality_and_incidence_7_countries_1568689974
Cancer survival mortality_and_incidence_7_countries_1568689974
 
Cancer survival: what is the role of body composition pre- and post-diagnosis...
Cancer survival: what is the role of body composition pre- and post-diagnosis...Cancer survival: what is the role of body composition pre- and post-diagnosis...
Cancer survival: what is the role of body composition pre- and post-diagnosis...
 
Jco 2010-rizzo-jco.2010.29.2201
Jco 2010-rizzo-jco.2010.29.2201Jco 2010-rizzo-jco.2010.29.2201
Jco 2010-rizzo-jco.2010.29.2201
 
Pituitary Tumor Endocrinopathies
Pituitary Tumor EndocrinopathiesPituitary Tumor Endocrinopathies
Pituitary Tumor Endocrinopathies
 
Aspirin Associated With Reduced Mortality in Patients With CRC.2015
Aspirin Associated With Reduced Mortality in Patients With CRC.2015Aspirin Associated With Reduced Mortality in Patients With CRC.2015
Aspirin Associated With Reduced Mortality in Patients With CRC.2015
 
The prevalence and characteristics of fibromyalgia in the 2012 national healt...
The prevalence and characteristics of fibromyalgia in the 2012 national healt...The prevalence and characteristics of fibromyalgia in the 2012 national healt...
The prevalence and characteristics of fibromyalgia in the 2012 national healt...
 
Tratamiento con osteobios en mujeres menopáusicas
Tratamiento con osteobios en mujeres menopáusicasTratamiento con osteobios en mujeres menopáusicas
Tratamiento con osteobios en mujeres menopáusicas
 

Similar to HTAI 2015 - Bariatric surgery impact on healthcare utilization in a brazilian private healthcare provider

08 exemplo de revisão sistemática
08   exemplo de revisão sistemática08   exemplo de revisão sistemática
08 exemplo de revisão sistemática
gisa_legal
 
The Global Burden of Disease (GBD) study
The Global Burden of Disease (GBD) studyThe Global Burden of Disease (GBD) study
The Global Burden of Disease (GBD) study
Δρ. Γιώργος K. Κασάπης
 
Breast cancer examinations in.docx
Breast cancer examinations in.docxBreast cancer examinations in.docx
Breast cancer examinations in.docx
stirlingvwriters
 
Developing a cancer survivorship research agenda - Prof Patricia Ganz
Developing a cancer survivorship research agenda - Prof Patricia GanzDeveloping a cancer survivorship research agenda - Prof Patricia Ganz
Developing a cancer survivorship research agenda - Prof Patricia Ganz
Irish Cancer Society
 
karan singh
karan singhkaran singh
karan singh
THCwIT Conference
 
BJUI Cystectomy
BJUI CystectomyBJUI Cystectomy
BJUI Cystectomy
Todd Manning
 
Physical Activity Levels and Health Quality of Life in Spanish Young Adults w...
Physical Activity Levels and Health Quality of Life in Spanish Young Adults w...Physical Activity Levels and Health Quality of Life in Spanish Young Adults w...
Physical Activity Levels and Health Quality of Life in Spanish Young Adults w...
semualkaira
 
Physical Activity Levels and Health Quality of Life in Spanish Young Adults w...
Physical Activity Levels and Health Quality of Life in Spanish Young Adults w...Physical Activity Levels and Health Quality of Life in Spanish Young Adults w...
Physical Activity Levels and Health Quality of Life in Spanish Young Adults w...
semualkaira
 
Strategies for Accelerating Translation of Research Findings into Cancer Prev...
Strategies for Accelerating Translation of Research Findings into Cancer Prev...Strategies for Accelerating Translation of Research Findings into Cancer Prev...
Strategies for Accelerating Translation of Research Findings into Cancer Prev...
Graham Colditz
 
Boston Nutrition Obesity Research Center: Contribution over 25 years obesity ...
Boston Nutrition Obesity Research Center: Contribution over 25 years obesity ...Boston Nutrition Obesity Research Center: Contribution over 25 years obesity ...
Boston Nutrition Obesity Research Center: Contribution over 25 years obesity ...
Graham Colditz
 
Cancer summitt 2020 buffalo aug 2011
Cancer summitt 2020 buffalo aug 2011 Cancer summitt 2020 buffalo aug 2011
Cancer summitt 2020 buffalo aug 2011
Camp Days
 
JACM-D-13-00014proof
JACM-D-13-00014proofJACM-D-13-00014proof
JACM-D-13-00014proof
Lucas Pauls
 
dfdffffffffffffffffffffffffffffffffffffffffffffy.pptx
dfdffffffffffffffffffffffffffffffffffffffffffffy.pptxdfdffffffffffffffffffffffffffffffffffffffffffffy.pptx
dfdffffffffffffffffffffffffffffffffffffffffffffy.pptx
ChanyutTuranon1
 
Obesity and Bariatric Surgery by Dr. Sanjiv Haribhakti
Obesity and Bariatric Surgery by Dr. Sanjiv HaribhaktiObesity and Bariatric Surgery by Dr. Sanjiv Haribhakti
Obesity and Bariatric Surgery by Dr. Sanjiv Haribhakti
Sanjiv Haribhakti
 
Reducing Readmissions and Length of Stay
Reducing Readmissions and Length of StayReducing Readmissions and Length of Stay
Reducing Readmissions and Length of Stay
VITAS Healthcare
 
Andhra Pradesh Priorities: NCDs - Seshadri
Andhra Pradesh Priorities: NCDs - SeshadriAndhra Pradesh Priorities: NCDs - Seshadri
Andhra Pradesh Priorities: NCDs - Seshadri
Copenhagen_Consensus
 
oncology-marketplace
oncology-marketplaceoncology-marketplace
oncology-marketplace
Ulrich Neumann, FRSA
 
Breast cancer and Covid ERA.pdf
Breast cancer and Covid ERA.pdfBreast cancer and Covid ERA.pdf
Breast cancer and Covid ERA.pdf
Mona Quenawy
 
Patient-Generated Data for Cancer Treatment and Management
Patient-Generated Data for Cancer Treatment and ManagementPatient-Generated Data for Cancer Treatment and Management
Patient-Generated Data for Cancer Treatment and Management
Tommy Snitz
 
Clinicopathologic Features and Survival Analysis of Non-metastatic Breast Can...
Clinicopathologic Features and Survival Analysis of Non-metastatic Breast Can...Clinicopathologic Features and Survival Analysis of Non-metastatic Breast Can...
Clinicopathologic Features and Survival Analysis of Non-metastatic Breast Can...
Hugo Raul Castro Salguero
 

Similar to HTAI 2015 - Bariatric surgery impact on healthcare utilization in a brazilian private healthcare provider (20)

08 exemplo de revisão sistemática
08   exemplo de revisão sistemática08   exemplo de revisão sistemática
08 exemplo de revisão sistemática
 
The Global Burden of Disease (GBD) study
The Global Burden of Disease (GBD) studyThe Global Burden of Disease (GBD) study
The Global Burden of Disease (GBD) study
 
Breast cancer examinations in.docx
Breast cancer examinations in.docxBreast cancer examinations in.docx
Breast cancer examinations in.docx
 
Developing a cancer survivorship research agenda - Prof Patricia Ganz
Developing a cancer survivorship research agenda - Prof Patricia GanzDeveloping a cancer survivorship research agenda - Prof Patricia Ganz
Developing a cancer survivorship research agenda - Prof Patricia Ganz
 
karan singh
karan singhkaran singh
karan singh
 
BJUI Cystectomy
BJUI CystectomyBJUI Cystectomy
BJUI Cystectomy
 
Physical Activity Levels and Health Quality of Life in Spanish Young Adults w...
Physical Activity Levels and Health Quality of Life in Spanish Young Adults w...Physical Activity Levels and Health Quality of Life in Spanish Young Adults w...
Physical Activity Levels and Health Quality of Life in Spanish Young Adults w...
 
Physical Activity Levels and Health Quality of Life in Spanish Young Adults w...
Physical Activity Levels and Health Quality of Life in Spanish Young Adults w...Physical Activity Levels and Health Quality of Life in Spanish Young Adults w...
Physical Activity Levels and Health Quality of Life in Spanish Young Adults w...
 
Strategies for Accelerating Translation of Research Findings into Cancer Prev...
Strategies for Accelerating Translation of Research Findings into Cancer Prev...Strategies for Accelerating Translation of Research Findings into Cancer Prev...
Strategies for Accelerating Translation of Research Findings into Cancer Prev...
 
Boston Nutrition Obesity Research Center: Contribution over 25 years obesity ...
Boston Nutrition Obesity Research Center: Contribution over 25 years obesity ...Boston Nutrition Obesity Research Center: Contribution over 25 years obesity ...
Boston Nutrition Obesity Research Center: Contribution over 25 years obesity ...
 
Cancer summitt 2020 buffalo aug 2011
Cancer summitt 2020 buffalo aug 2011 Cancer summitt 2020 buffalo aug 2011
Cancer summitt 2020 buffalo aug 2011
 
JACM-D-13-00014proof
JACM-D-13-00014proofJACM-D-13-00014proof
JACM-D-13-00014proof
 
dfdffffffffffffffffffffffffffffffffffffffffffffy.pptx
dfdffffffffffffffffffffffffffffffffffffffffffffy.pptxdfdffffffffffffffffffffffffffffffffffffffffffffy.pptx
dfdffffffffffffffffffffffffffffffffffffffffffffy.pptx
 
Obesity and Bariatric Surgery by Dr. Sanjiv Haribhakti
Obesity and Bariatric Surgery by Dr. Sanjiv HaribhaktiObesity and Bariatric Surgery by Dr. Sanjiv Haribhakti
Obesity and Bariatric Surgery by Dr. Sanjiv Haribhakti
 
Reducing Readmissions and Length of Stay
Reducing Readmissions and Length of StayReducing Readmissions and Length of Stay
Reducing Readmissions and Length of Stay
 
Andhra Pradesh Priorities: NCDs - Seshadri
Andhra Pradesh Priorities: NCDs - SeshadriAndhra Pradesh Priorities: NCDs - Seshadri
Andhra Pradesh Priorities: NCDs - Seshadri
 
oncology-marketplace
oncology-marketplaceoncology-marketplace
oncology-marketplace
 
Breast cancer and Covid ERA.pdf
Breast cancer and Covid ERA.pdfBreast cancer and Covid ERA.pdf
Breast cancer and Covid ERA.pdf
 
Patient-Generated Data for Cancer Treatment and Management
Patient-Generated Data for Cancer Treatment and ManagementPatient-Generated Data for Cancer Treatment and Management
Patient-Generated Data for Cancer Treatment and Management
 
Clinicopathologic Features and Survival Analysis of Non-metastatic Breast Can...
Clinicopathologic Features and Survival Analysis of Non-metastatic Breast Can...Clinicopathologic Features and Survival Analysis of Non-metastatic Breast Can...
Clinicopathologic Features and Survival Analysis of Non-metastatic Breast Can...
 

More from REBRATSoficial

Desafios na Avaliação de Tecnologias para o Enfrentamento ao Aedes/Zika/Micro...
Desafios na Avaliação de Tecnologias para o Enfrentamento ao Aedes/Zika/Micro...Desafios na Avaliação de Tecnologias para o Enfrentamento ao Aedes/Zika/Micro...
Desafios na Avaliação de Tecnologias para o Enfrentamento ao Aedes/Zika/Micro...
REBRATSoficial
 
Perfil de expressão diferencial de microRNAs plasmáticos como ferramenta para...
Perfil de expressão diferencial de microRNAs plasmáticos como ferramenta para...Perfil de expressão diferencial de microRNAs plasmáticos como ferramenta para...
Perfil de expressão diferencial de microRNAs plasmáticos como ferramenta para...
REBRATSoficial
 
Desinvestimento - Centro Cochrane do Brasil
Desinvestimento - Centro Cochrane do BrasilDesinvestimento - Centro Cochrane do Brasil
Desinvestimento - Centro Cochrane do Brasil
REBRATSoficial
 
Efetividade clínica comparativa e custo-efetividade do análogo de insulina Gl...
Efetividade clínica comparativa e custo-efetividade do análogo de insulina Gl...Efetividade clínica comparativa e custo-efetividade do análogo de insulina Gl...
Efetividade clínica comparativa e custo-efetividade do análogo de insulina Gl...
REBRATSoficial
 
ALTERAÇÕES CARDIOVASCULARES E SÍNDROME METABÓLICA EM ADULTOS E IDOSOS DE RIO ...
ALTERAÇÕES CARDIOVASCULARES E SÍNDROME METABÓLICA EM ADULTOS E IDOSOS DE RIO ...ALTERAÇÕES CARDIOVASCULARES E SÍNDROME METABÓLICA EM ADULTOS E IDOSOS DE RIO ...
ALTERAÇÕES CARDIOVASCULARES E SÍNDROME METABÓLICA EM ADULTOS E IDOSOS DE RIO ...
REBRATSoficial
 
Desenvolvimento, implantação e análise de um sistema (web) informatizado de r...
Desenvolvimento, implantação e análise de um sistema (web) informatizado de r...Desenvolvimento, implantação e análise de um sistema (web) informatizado de r...
Desenvolvimento, implantação e análise de um sistema (web) informatizado de r...
REBRATSoficial
 
Intervenções educacionais para aumentar o controle da pressão arterial em pac...
Intervenções educacionais para aumentar o controle da pressão arterial em pac...Intervenções educacionais para aumentar o controle da pressão arterial em pac...
Intervenções educacionais para aumentar o controle da pressão arterial em pac...
REBRATSoficial
 
Análise comparativa da adesão ao tratamento anti-hipertensivo e qualidade de ...
Análise comparativa da adesão ao tratamento anti-hipertensivo e qualidade de ...Análise comparativa da adesão ao tratamento anti-hipertensivo e qualidade de ...
Análise comparativa da adesão ao tratamento anti-hipertensivo e qualidade de ...
REBRATSoficial
 
Análise de custo-efetividade do tratamento de doenças venosas crônicas (DVC) ...
Análise de custo-efetividade do tratamento de doenças venosas crônicas (DVC) ...Análise de custo-efetividade do tratamento de doenças venosas crônicas (DVC) ...
Análise de custo-efetividade do tratamento de doenças venosas crônicas (DVC) ...
REBRATSoficial
 
Avaliação de Riscos Potenciais em Serviços de Hemodinâmica de três Estados Br...
Avaliação de Riscos Potenciais em Serviços de Hemodinâmica de três Estados Br...Avaliação de Riscos Potenciais em Serviços de Hemodinâmica de três Estados Br...
Avaliação de Riscos Potenciais em Serviços de Hemodinâmica de três Estados Br...
REBRATSoficial
 
Avaliação de Segurança e Efetividade de Incubadoras Neonatais em Uso.
Avaliação de Segurança e Efetividade de Incubadoras Neonatais em Uso.Avaliação de Segurança e Efetividade de Incubadoras Neonatais em Uso.
Avaliação de Segurança e Efetividade de Incubadoras Neonatais em Uso.
REBRATSoficial
 
Avaliação da parametrização para tomógrafos computadorizados e ressonância ma...
Avaliação da parametrização para tomógrafos computadorizados e ressonância ma...Avaliação da parametrização para tomógrafos computadorizados e ressonância ma...
Avaliação da parametrização para tomógrafos computadorizados e ressonância ma...
REBRATSoficial
 
Comparação da acurácia diagnóstica de testes diagnósticos comerciais imunocro...
Comparação da acurácia diagnóstica de testes diagnósticos comerciais imunocro...Comparação da acurácia diagnóstica de testes diagnósticos comerciais imunocro...
Comparação da acurácia diagnóstica de testes diagnósticos comerciais imunocro...
REBRATSoficial
 
Estudo de Acurácia da Fotografia Digital para Rastreamento de Retinopatia Dia...
Estudo de Acurácia da Fotografia Digital para Rastreamento de Retinopatia Dia...Estudo de Acurácia da Fotografia Digital para Rastreamento de Retinopatia Dia...
Estudo de Acurácia da Fotografia Digital para Rastreamento de Retinopatia Dia...
REBRATSoficial
 
PTC - EFICÁCIA E SEGURANÇA DO SELANTE HEMOSTÁTICO DE FIBRINA EM ARTROPLASTIAS...
PTC - EFICÁCIA E SEGURANÇA DO SELANTE HEMOSTÁTICO DE FIBRINA EM ARTROPLASTIAS...PTC - EFICÁCIA E SEGURANÇA DO SELANTE HEMOSTÁTICO DE FIBRINA EM ARTROPLASTIAS...
PTC - EFICÁCIA E SEGURANÇA DO SELANTE HEMOSTÁTICO DE FIBRINA EM ARTROPLASTIAS...
REBRATSoficial
 
Judicialização no Ministério da Saúde
Judicialização no Ministério da SaúdeJudicialização no Ministério da Saúde
Judicialização no Ministério da Saúde
REBRATSoficial
 
Apresentação do Dr. Luiz Ary Messina - Telessaúde.
Apresentação do Dr. Luiz Ary Messina - Telessaúde.Apresentação do Dr. Luiz Ary Messina - Telessaúde.
Apresentação do Dr. Luiz Ary Messina - Telessaúde.
REBRATSoficial
 
Apresentação Louisa Stuwe - HTAi 2015 - 08 junho.
Apresentação Louisa Stuwe - HTAi 2015 - 08 junho.Apresentação Louisa Stuwe - HTAi 2015 - 08 junho.
Apresentação Louisa Stuwe - HTAi 2015 - 08 junho.
REBRATSoficial
 
HTAi 2015 - Profile of the effectiveness of detection of atypia by the cervic...
HTAi 2015 - Profile of the effectiveness of detection of atypia by the cervic...HTAi 2015 - Profile of the effectiveness of detection of atypia by the cervic...
HTAi 2015 - Profile of the effectiveness of detection of atypia by the cervic...
REBRATSoficial
 
HTAi 2015 - Procurement of protein kinase inhibitors in Brazil: A scoping study
HTAi 2015 - Procurement of protein kinase inhibitors in Brazil: A scoping studyHTAi 2015 - Procurement of protein kinase inhibitors in Brazil: A scoping study
HTAi 2015 - Procurement of protein kinase inhibitors in Brazil: A scoping study
REBRATSoficial
 

More from REBRATSoficial (20)

Desafios na Avaliação de Tecnologias para o Enfrentamento ao Aedes/Zika/Micro...
Desafios na Avaliação de Tecnologias para o Enfrentamento ao Aedes/Zika/Micro...Desafios na Avaliação de Tecnologias para o Enfrentamento ao Aedes/Zika/Micro...
Desafios na Avaliação de Tecnologias para o Enfrentamento ao Aedes/Zika/Micro...
 
Perfil de expressão diferencial de microRNAs plasmáticos como ferramenta para...
Perfil de expressão diferencial de microRNAs plasmáticos como ferramenta para...Perfil de expressão diferencial de microRNAs plasmáticos como ferramenta para...
Perfil de expressão diferencial de microRNAs plasmáticos como ferramenta para...
 
Desinvestimento - Centro Cochrane do Brasil
Desinvestimento - Centro Cochrane do BrasilDesinvestimento - Centro Cochrane do Brasil
Desinvestimento - Centro Cochrane do Brasil
 
Efetividade clínica comparativa e custo-efetividade do análogo de insulina Gl...
Efetividade clínica comparativa e custo-efetividade do análogo de insulina Gl...Efetividade clínica comparativa e custo-efetividade do análogo de insulina Gl...
Efetividade clínica comparativa e custo-efetividade do análogo de insulina Gl...
 
ALTERAÇÕES CARDIOVASCULARES E SÍNDROME METABÓLICA EM ADULTOS E IDOSOS DE RIO ...
ALTERAÇÕES CARDIOVASCULARES E SÍNDROME METABÓLICA EM ADULTOS E IDOSOS DE RIO ...ALTERAÇÕES CARDIOVASCULARES E SÍNDROME METABÓLICA EM ADULTOS E IDOSOS DE RIO ...
ALTERAÇÕES CARDIOVASCULARES E SÍNDROME METABÓLICA EM ADULTOS E IDOSOS DE RIO ...
 
Desenvolvimento, implantação e análise de um sistema (web) informatizado de r...
Desenvolvimento, implantação e análise de um sistema (web) informatizado de r...Desenvolvimento, implantação e análise de um sistema (web) informatizado de r...
Desenvolvimento, implantação e análise de um sistema (web) informatizado de r...
 
Intervenções educacionais para aumentar o controle da pressão arterial em pac...
Intervenções educacionais para aumentar o controle da pressão arterial em pac...Intervenções educacionais para aumentar o controle da pressão arterial em pac...
Intervenções educacionais para aumentar o controle da pressão arterial em pac...
 
Análise comparativa da adesão ao tratamento anti-hipertensivo e qualidade de ...
Análise comparativa da adesão ao tratamento anti-hipertensivo e qualidade de ...Análise comparativa da adesão ao tratamento anti-hipertensivo e qualidade de ...
Análise comparativa da adesão ao tratamento anti-hipertensivo e qualidade de ...
 
Análise de custo-efetividade do tratamento de doenças venosas crônicas (DVC) ...
Análise de custo-efetividade do tratamento de doenças venosas crônicas (DVC) ...Análise de custo-efetividade do tratamento de doenças venosas crônicas (DVC) ...
Análise de custo-efetividade do tratamento de doenças venosas crônicas (DVC) ...
 
Avaliação de Riscos Potenciais em Serviços de Hemodinâmica de três Estados Br...
Avaliação de Riscos Potenciais em Serviços de Hemodinâmica de três Estados Br...Avaliação de Riscos Potenciais em Serviços de Hemodinâmica de três Estados Br...
Avaliação de Riscos Potenciais em Serviços de Hemodinâmica de três Estados Br...
 
Avaliação de Segurança e Efetividade de Incubadoras Neonatais em Uso.
Avaliação de Segurança e Efetividade de Incubadoras Neonatais em Uso.Avaliação de Segurança e Efetividade de Incubadoras Neonatais em Uso.
Avaliação de Segurança e Efetividade de Incubadoras Neonatais em Uso.
 
Avaliação da parametrização para tomógrafos computadorizados e ressonância ma...
Avaliação da parametrização para tomógrafos computadorizados e ressonância ma...Avaliação da parametrização para tomógrafos computadorizados e ressonância ma...
Avaliação da parametrização para tomógrafos computadorizados e ressonância ma...
 
Comparação da acurácia diagnóstica de testes diagnósticos comerciais imunocro...
Comparação da acurácia diagnóstica de testes diagnósticos comerciais imunocro...Comparação da acurácia diagnóstica de testes diagnósticos comerciais imunocro...
Comparação da acurácia diagnóstica de testes diagnósticos comerciais imunocro...
 
Estudo de Acurácia da Fotografia Digital para Rastreamento de Retinopatia Dia...
Estudo de Acurácia da Fotografia Digital para Rastreamento de Retinopatia Dia...Estudo de Acurácia da Fotografia Digital para Rastreamento de Retinopatia Dia...
Estudo de Acurácia da Fotografia Digital para Rastreamento de Retinopatia Dia...
 
PTC - EFICÁCIA E SEGURANÇA DO SELANTE HEMOSTÁTICO DE FIBRINA EM ARTROPLASTIAS...
PTC - EFICÁCIA E SEGURANÇA DO SELANTE HEMOSTÁTICO DE FIBRINA EM ARTROPLASTIAS...PTC - EFICÁCIA E SEGURANÇA DO SELANTE HEMOSTÁTICO DE FIBRINA EM ARTROPLASTIAS...
PTC - EFICÁCIA E SEGURANÇA DO SELANTE HEMOSTÁTICO DE FIBRINA EM ARTROPLASTIAS...
 
Judicialização no Ministério da Saúde
Judicialização no Ministério da SaúdeJudicialização no Ministério da Saúde
Judicialização no Ministério da Saúde
 
Apresentação do Dr. Luiz Ary Messina - Telessaúde.
Apresentação do Dr. Luiz Ary Messina - Telessaúde.Apresentação do Dr. Luiz Ary Messina - Telessaúde.
Apresentação do Dr. Luiz Ary Messina - Telessaúde.
 
Apresentação Louisa Stuwe - HTAi 2015 - 08 junho.
Apresentação Louisa Stuwe - HTAi 2015 - 08 junho.Apresentação Louisa Stuwe - HTAi 2015 - 08 junho.
Apresentação Louisa Stuwe - HTAi 2015 - 08 junho.
 
HTAi 2015 - Profile of the effectiveness of detection of atypia by the cervic...
HTAi 2015 - Profile of the effectiveness of detection of atypia by the cervic...HTAi 2015 - Profile of the effectiveness of detection of atypia by the cervic...
HTAi 2015 - Profile of the effectiveness of detection of atypia by the cervic...
 
HTAi 2015 - Procurement of protein kinase inhibitors in Brazil: A scoping study
HTAi 2015 - Procurement of protein kinase inhibitors in Brazil: A scoping studyHTAi 2015 - Procurement of protein kinase inhibitors in Brazil: A scoping study
HTAi 2015 - Procurement of protein kinase inhibitors in Brazil: A scoping study
 

Recently uploaded

Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
MedicoseAcademics
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
reignlana06
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Jim Jacob Roy
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
LaniyaNasrink
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
taiba qazi
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Tina Purnat
 
THERAPEUTIC ANTISENSE MOLECULES .pptx
THERAPEUTIC ANTISENSE MOLECULES    .pptxTHERAPEUTIC ANTISENSE MOLECULES    .pptx
THERAPEUTIC ANTISENSE MOLECULES .pptx
70KRISHPATEL
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
BrissaOrtiz3
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
19various
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
Dhayanithi C
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
Swastik Ayurveda
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
rightmanforbloodline
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
AksshayaRajanbabu
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 

Recently uploaded (20)

Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
 
THERAPEUTIC ANTISENSE MOLECULES .pptx
THERAPEUTIC ANTISENSE MOLECULES    .pptxTHERAPEUTIC ANTISENSE MOLECULES    .pptx
THERAPEUTIC ANTISENSE MOLECULES .pptx
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 

HTAI 2015 - Bariatric surgery impact on healthcare utilization in a brazilian private healthcare provider

  • 1. BARIATRIC SURGERY IMPACT ON HEALTHCARE UTILIZATION IN A BRAZILIAN PRIVATE HEALTHCARE PROVIDER Silvana M B Kelles, Luíza O Rodrigues, Augusto C S Santos Júnior, Daniela C Azevedo, Lélia M A Carvalho, Maria da Glória C Horta, Mariana R Fernandes, Sandra O S Avelar, Carla J Machado, Sandhi M Barreto. UNIMED BH and Universidade Federal de Minas Gerais (UFMG) ABSTRACT METHODS RESULTS - TABLE In Brazil, the prevalence of obesity is steadily increasing at a rate of 0.89% per year. It is currently well known that obese and extremely obese individuals are more likely to have associated comorbidities, lower quality of life and shorter life expectancy compared to normal-weight individuals. Also, morbidly obese individuals increase their health care utilization and cost in about 81% when compared to a non-obese population, and in 47% when compared to a non-morbidly obese population. Clinical benefits of bariatric surgery seem established, such as sustainable weight loss and reduction in the prevalence of obesity-related comorbidities. On the other hand, its mid-term impact on healthcare utilization and costs remains controversial. Thus, the objectives of this study was to analyze healthcare use and expenditures, before and after bariatric surgery, in a cohort of Brazilian patients assisted by an HMO (UNIMED BH). RESULTS This study consisted of a health insurance database analysis, from which before-and-after utilization profile, per-operative problems, long-term surgical complications, and cost-utility issues were obtained for all patients who underwent bariatric surgery (from January 2004 to December 2010). Patients fulfilled the following bariatric surgery eligibility criteria, established by The National Institutes of Health: BMI≥40 kg/m² or BMI ≥35 kg/m² and comorbid conditions, such as hypertension, diabetes, sleep apnea, or severe arthropathy. Individuals under 18 years of age were excluded. Data concerning healthcare costs and utilization were retrospectively analyzed, excluding the six months immediately before or after surgery. RESULTS During the study period, 4,006 patients underwent bariatric surgery. Patients’ baseline characteristics were: mean age of 36.2 (SD 10.3) years, mean BMI of 42.8 (SD 4.8) kg/m², and 80% were women. There was a consistent increase in hospital admissions after surgery (total admissions were 740 vs. 1,231; p<0.001), even when hospitalizations for plastic surgery or pregnancy-related were excluded, with a global rate of 11.89 vs. 30.18 hospitalizations per 1,000 patients/year (p<0.001). Visits to the emergency room (ER) were less frequent in the first year, but more frequent in the third year of follow up. The overall rates of ER visits were 189.61 visits per 1,000 patients/year before surgery and 170.18 after (p=0.022). The overall healthcare expenses before and after the surgery were US$ 350 and US$ 520 per person per year, respectively (p<0.001). Figure 1: Rate of hospital admissions in the 4 years before and after bariatric surgery (excluding the six months immediately before and after surgery and the admissions related to plastic surgery or pregnancy). The differences between the respective years before and after surgery were all statistically significant (P<0.05). Hospital admissions per 1,000 patients/year
  • 2. BARIATRIC SURGERY IMPACT ON HEALTHCARE UTILIZATION IN A BRAZILIAN PRIVATE HEALTHCARE PROVIDER Silvana M B Kelles, Luíza O Rodrigues, Augusto C S Santos Júnior, Daniela C Azevedo, Lélia M A Carvalho, Maria da Glória C Horta, Mariana R Fernandes, Sandra O S Avelar, Carla J Machado, Sandhi M Barreto. UNIMED BH and Universidade Federal de Minas Gerais (UFMG) RESULTSRESULTS CONCLUSIONS Figure 2: Average health care expenditures per patient, per semester, during the four years before (B) and after (A) bariatric surgery. 1. Fontaine KR, Redden DT, Wang C, Westfall AO, Allison DB. Years of life lost due to obesity. JAMA 2003;289:187-93. 2. Malta DC, Andrade SC, Claro RM, Bernal RTI, Monteiro CA. Trends in prevalence of overweight and obesity in adults in 26 Brazilian state capitals and the Federal District from 2006 to 2012. Rev Bras Epidemiol. 2014;17 Suppl 1:267-276.. 3. Boido A, Ceriani V, Cetta F, Lombardi F, Pontiroli AE. Bariatric surgery and prevention of cardiovascular events and mortality in morbid obesity: mechanisms of action and choice of surgery. Nutr Metab Cardiovasc Dis. 2015. 4. KELLES SMB, MACHADO CJ, BARRETO SM. Ten-years of bariatric surgery in Brazil: in-hospital mortality rates for patients assisted by universal health system or a health maintenance organization. ABCD Arq Bras Cir Dig (São Paulo). 2014;27(4):261-267. REFERENCES Costs and hospital admissions increased consistently after bariatric surgery, even when elective or pregnancy-related interventions were excluded. Healthcare providers and policy makers must be aware that a decrease in obesity-related diseases following bariatric surgery does not necessarily result in lower mid-term healthcare utilization or costs. Time trends illustrated in this study suggest that healthcare costs might decrease to pre-surgery levels in the long term. Healthcare providers must also consider a broader evaluation of healthcare utilization and costs associated with bariatric surgery, including the impacts on quality of life, mortality and morbidity associated with the surgery, and daily use of medication, in order to provide a more comprehensive evaluation of changes before and after surgery.